It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Melanosomes, lipofuscin, and melanolipofuscin are the three principal types of pigmented granules found in retinal pigment epithelium (RPE) cells. Changes in the density of melanosomes and lipofuscin in RPE cells are considered hallmarks of various retinal diseases, including Stargardt disease and age-related macular degeneration (AMD). Herein, we report the potential of an in vivo multimodal imaging technique based on directional back-scattering and short-wavelength fundus autofluorescence (SW-FAF) to study disease-related changes in the density of melanosomes and lipofuscin granules in RPE cells. Changes in the concentration of these granules in Abca4−/− mice (a model of Stargardt disease) relative to age-matched wild-type (WT) controls were investigated. Directional optical coherence tomography (dOCT) was used to assess melanosome density in vivo, whereas the autofluorescence (AF) images and emission spectra acquired with a spectrometer-integrated scanning laser ophthalmoscope (SLO) were used to characterize lipofuscin and melanolipofuscin granules in the same RPE region. Subcellular-resolution ex vivo imaging using confocal fluorescence microscopy and electron microscopy was performed on the same tissue region to visualize and quantify melanosomes, lipofuscin, and melanolipofuscin granules. Comparisons between in vivo and ex vivo results confirmed an increased concentration of lipofuscin granules and decreased concentration of melanosomes in the RPE of Abca4−/− mice, and provided an explanation for the differences in fluorescence and directionality of RPE scattering observed in vivo between the two mouse strains.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of California Davis, UC Davis Eyepod Imaging Laboratory, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684); University of California Davis, Department of Cell Biology and Human Anatomy, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684); University of California Davis, Department of Ophthalmology and Vision Science, Sacramento, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
2 University of California Davis, Center for Neuroscience, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
3 University of California Davis, Department of Cell Biology and Human Anatomy, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
4 University of California Davis, Center for Neuroscience, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684); University of California Davis, Department of Ophthalmology and Vision Science, Sacramento, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
5 University of California Davis, UC Davis Eyepod Imaging Laboratory, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684); University of California Davis, Department of Cell Biology and Human Anatomy, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)